Genomic Tests Results in Major Advances in Breast Cancer Treatment

By Adam Brufsky, MD, PhD on Sep 25, 2018 12:40:00 PM

As a practicing medical oncologist with a specialty in breast cancer for the past 22 years, I have been fortunate to see substantial advances in treatment. A majority of women are now diagnosed with early stage disease, and five-year survivals without recurrence for women with estrogen receptor positive stage I and II breast cancer now exceed 85-90%. The question I now deal with is not: “Will I survive this,” but rather, “What will it take to get me there?”

Continue Reading